UNSPSC 85532275: Bypass right greater saphenous vein to lower vein with autologous venous tissue, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass right greater saphenous vein to lower vein with autologous venous tissue, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 061P49Y

UNSPSC 85532275 Bypass right greater saphenous vein to lower vein with autologous venous tissue, percutaneous endoscopic approach is a Commodity code that does not align with the state and local procurement activity posted under it. The recent solicitations tagged to this code—independent medical evaluation services for pension disability determinations, surgical procedure carve-out benefits for municipal employees, occupational medical surveillance for state ferry workers, emergency and specialty medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing—reflect general healthcare administration, benefits management, and occupational health services rather than a specific vascular surgical procedure. The code's nominal scope describes a highly specialized surgical intervention, yet no state or local opportunities in the source reference vascular bypass procedures, surgical supply procurement, or related orthopedic or cardiovascular device and instrumentation contracting. The issuing bodies include cities (Phoenix, Long Beach), counties (Harris County, Collier County, Santa Clara County), a state transportation department (Washington State Department of Transportation), and a regional health system, but none of these solicitations target the clinical procedure named in the code.

The mismatch between the code label and actual procurement activity suggests either a tagging error in the state or local notice system or a code that sees little genuine activity in the markets covered by these opportunities. Without recent opportunities that actually solicit vascular bypass supplies, surgical instrumentation, physician services for this specific procedure, or implantable materials aligned with the code's scope, there is no reliable signal of current market demand or issuing-body concentration under this code at the state and local level.